OSCAR HEALTH INC - CLASS A (OSCR)

US6877931096 - Common Stock

16.45  +0.91 (+5.86%)

After market: 16.22 -0.23 (-1.4%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to OSCR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 17.51. This target is 6.44% above the current price.
OSCR was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about OSCR.
In the previous month the buy percentage consensus was at a similar level.
OSCR was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 16.458.0819.8917.5121.00 - -50.88% 20.91% 6.44% 27.66%
Up and Down Grades
Date Firm Action Rating
2024-03-22 Raymond James Initiate Outperform
2024-02-15 Wells Fargo Maintains Overweight -> Overweight
2024-02-09 Goldman Sachs Maintains Neutral -> Neutral
2023-11-02 B of A Securities Upgrade Neutral -> Buy
2023-08-30 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-08-10 Goldman Sachs Maintains Neutral -> Neutral
2023-08-09 Credit Suisse Maintains Outperform -> Outperform
2023-07-14 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-06-13 Wells Fargo Maintains Overweight
2023-06-06 B of A Securities Upgrade Underperform -> Neutral
2023-05-17 Wells Fargo Maintains Overweight -> Overweight
2023-05-10 Credit Suisse Maintains Outperform
2023-03-29 B of A Securities Maintains Underperform
2023-02-14 Cowen & Co. Maintains Market Perform
2023-02-14 Goldman Sachs Maintains Neutral
2023-02-10 Credit Suisse Maintains Outperform
2022-11-16 Wells Fargo Upgrade Equal-Weight -> Overweight
2022-11-14 Morgan Stanley Downgrade Overweight -> Equal-Weight
2022-09-01 Morgan Stanley Maintains Overweight
2022-06-15 B of A Securities Downgrade Neutral -> Underperform
2022-06-09 Morgan Stanley Maintains Overweight
2022-05-26 B of A Securities Downgrade Buy -> Neutral
2022-02-14 Goldman Sachs Upgrade Sell -> Neutral
2022-02-14 Morgan Stanley Maintains Overweight
2022-01-07 Credit Suisse Maintains Outperform
2022-01-06 Wells Fargo Downgrade Overweight -> Equal-Weight
2021-12-17 Morgan Stanley Maintains Overweight
2021-12-14 Goldman Sachs Initiate Sell
2021-11-11 Credit Suisse Maintains Outperform
2021-08-31 Morgan Stanley Maintains Overweight